Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients
NCT ID: NCT03306914
Last Updated: 2020-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2017-10-15
2019-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhancing Renal Graft Function During Donor Anesthesia
NCT03778944
Continuous Spinal Anesthesia in Renal Transplantation
NCT03436368
Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation
NCT06535945
Enhanced Recovery After Surgery in Kidney Transplant Donors
NCT04110080
Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation
NCT01675089
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Albumin group
Albumin resuscitation Albumin 5%
Albumin resuscitation
Albumin 5% is used as the intra-operative colloid
Albumin 5%
Infusion of Albumin 5% intra-operatively
Hydroxyethylstarch group
Hydroxyethylstarch resuscitation Hydroxyethylstarch 6%
Hydroxyethylstarch resuscitation
Hydroxyethyl starch 6% is used as the intra-operative colloid
Hydroxyethylstarch 6%
Infusion of Hydroxyethylstarch 6% intra-operatively
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Albumin resuscitation
Albumin 5% is used as the intra-operative colloid
Hydroxyethylstarch resuscitation
Hydroxyethyl starch 6% is used as the intra-operative colloid
Albumin 5%
Infusion of Albumin 5% intra-operatively
Hydroxyethylstarch 6%
Infusion of Hydroxyethylstarch 6% intra-operatively
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Kareem
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed Kareem
Role: STUDY_DIRECTOR
Kasr Al-Ainy Hospiral, Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Albumin versus starch
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.